Premium
Sabotaging of the oxidative stress response by an oncogenic noncoding RNA
Author(s) -
Mahajan Nitin,
Wu HuaJun,
Bennett Richard L.,
Troche Catalina,
Licht Jonathan D.,
Weber Jason D.,
Maggi Leonard B.,
Tomasson Michael H.
Publication year - 2017
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.201600654r
Subject(s) - reactive oxygen species , oxidative stress , cell growth , biology , microbiology and biotechnology , gene , rna , phosphorylation , cancer research , genetics , biochemistry
Overexpression of the multiple myeloma set domain ( MMSET ) Wolf‐Hirschhorn syndrome candidate 1 gene, which contains an orphan box H/ACA class small nucleolar RNA, ACA11, in an intron, is associated with several cancer types, including multiple myeloma (MM). ACA11 and MMSET are overexpressed cotranscriptionally as a result of the t (4;14) chromosomal translocation in a subset of patients with MM. RNA sequencing of CD138+ tumor cells from t (4;14)‐positive and ‐negative MM patient bone marrow samples revealed an enhanced oxidative phosphorylation mRNA signature. Supporting these data, ACA11 overexpression in a t (4;14)‐negative MM cell line, MM1.S, demonstrated enhanced reactive oxygen species (ROS) levels. In addition, an enhancement of cell proliferation, increased soft agar colony size, and elevated ERK1/2 phosphorylation were observed. This ACA11‐driven hyperproliferative phenotype depended on increased ROS levels as exogenously added antioxidants attenuate the increased proliferation. A major transcriptional regulator of the cellular antioxidant response, nuclear factor (erythroid‐derived 2)‐like 2 (NRF2), shuttled to the nucleus, as expected, in response to ACA11‐driven increases in ROS; however, transcriptional up‐regulation of some of NRF2's antioxidant target genes was abrogated in the presence of ACA11 overexpression. These data show for the first time that ACA11 promotes proliferation through inhibition of NRF2 function resulting in sustained ROS levels driving cancer cell proliferation.—Mahajan, N., Wu, H.‐J., Bennett, R.L., Troche, C., Licht, J.D., Weber, J. D., Maggi, L. B., Jr., Tomasson, M. H. Sabotaging of the oxidative stress response by an oncogenic noncoding RNA. FASEB J. 31, 482–490 (2017). www.fasebj.org